A study on ultrasound based transdermal drug delivery system by Maddheshiya, Sanjeet Kumar
I 
 
A STUDY ON ULTRASOUND BASED 
TRANSDERMAL DRUG DELIVERY SYSTEM 
 
Thesis submitted in partial fulfillment of the requirements for the degree 
 
  of 
 
 Master of Technology 
 
  in 
 
               Biomedical Engineering 
 
  by 
 
                       SANJEET KUMAR MADDHESHIYA 
 
     Roll No: 211BM1214 
 
                                 
 
 
 Department of Biotechnology & Medical Engineering 
                                      National Institute of Technology 
                                                               Rourkela 
    2011-2013 
II 
 
A STUDY ON ULTRASOUND BASED TRANSDERMAL 
DRUG DELIVERY SYSTEM 
 
Thesis submitted in partial fulfillment of the requirements for the degree 
 
  of 
 
Master of Technology 
 
  in 
 
              Biomedical Engineering 
 
  by 
 
                      SANJEET KUMAR MADDHESHIYA 
 
    Roll No: 211BM1214 
 
                                     Under the guidance of 
 
                                   Prof. Indranil Banerjee 
                                              Assistant Professor 
 
Department of Biotechnology & Medical Engineering 
                                     National Institute of Technology 
                                                               Rourkela 
    2011-2013 
III 
 
 
NATIONAL INSTITUTE OF TECHNOLOGY, ROURKELA 
 
 
CERTIFICATE 
 
 
 This is to certify that the thesis entitled, “A STUDY ON ULTRASOUND BASED 
TRANSDERMAL DRUG DELIVERY SYSTEM” submitted by Mr. SANJEET KUMAR 
MADDHESHIYA in partial fulfillment of the requirements for the award of degree of 
Master of Technology degree in Biotechnology & Medical Engineering with specialization 
in “Biomedical Engineering” at National Institute of Technology, Rourkela is an authentic 
work carried out by him under my supervision and guidance. 
 To the best of my knowledge, the matter embodied in the thesis has not been 
submitted to any other university/institute for the award of any Degree or Diploma. 
 
 
 
 
 
Date: 04/06/2013                                                                            Prof. Indranil Banerjee                                                         
                                                                                                         Assistant Professor 
                                                                  Department of Biotechnology &  
                                                                                                           Medical Engineering 
                                                                                                               NIT Rourkela 
 
 
 
IV 
 
 
NATIONAL INSTITUTE OF TECHNOLOGY, ROURKELA 
 
ACKNOWLEDGMENT 
 
 
 I would like to express my gratitude to my supervisor Prof. Indranil Banerjee for 
his patience, motivation, enthusiasm, immense knowledge and constant support. His 
guidance has helped me throughout my project work and in writing my thesis at NIT, 
Rourkela. 
 Besides my advisor, I would like to thank Prof. Kunal Pal, Prof. Sirsendu Sekhar 
Ray, Prof. Bibhukalyan Prasad Nayak, for their encouragement and insightful comments. 
 I would like to thank all faculty members and staff of the Department of 
Biotechnology & Medical Engineering, N.I.T. Rourkela for their generous help in various 
ways for the completion of this thesis. 
 I would like to thank all my friends and especially my classmates for all the 
discussions. I’ve enjoyed their companionship during my stay at NIT, Rourkela. 
 I am especially indebted to my parents for their love, sacrifice, and support. My full 
dedication to the work would have not been possible without their blessings and moral 
support. This thesis is a dedication to them. 
 
 
Date: 04.06.2013                                                   SANJEET KUMAR MADDHESHIYA                                                                                   
                                                                                                        211BM1214 
                                                                                        Department of Biotechnology &  
                                                                                                   Medical Engineering 
                                                                                      NIT Rourkela 
V 
 
ABSTRACT 
 
 
 
 The development of an ultrasound based Transdermal drug delivery device (or 
sonophoresis) has received increased attention over the past few years. Meaningful 
enhanced carrying of model drugs such as mannitol and insulin has been determined using 
commercial sonicators. However, its practical use is hampered by its large size and weight 
of the common ultrasound transducer devices. In this project work, a remote controlled drug 
delivery system (sonophoresis device) with a flat flextensional ultrasound transducer was 
proposed. It is clearly known that low frequency ultrasound can be used to enhance 
transdermal drug penetration which is known as sonophoresis. Scientifically, acoustic 
cavitations outcome in the creation of defects in the stratum corneum allows accelerated 
absorption of currently applied molecules. The aim of this study was to develop a low cast 
optimized remotely controlled sonophoresis device with variable resonant frequency for 
studying Transdermal drug delivery in vitro. Following acoustic validation, 21.75 kHz 
ultrasound was applied for different durations (range: 5 s to1 min) using three different 
modes (10%, 33% or 100% duty cycles). The simulation result of first resonance frequency 
was found to be comparable to that of the experimental result. In comparison with the other 
types of sonophoresis device, it has a simple structure and its fabrication process is easy and 
inexpensive. 
 
Keywords: Sonophoresis, Drug delivery, Remote Controlled, Microcontroller (AT89C51), 
Optimized, Sonophoresis device, Ultrasound, Transdermal drug delivery system. 
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1.1 Introduction 
The project entitled “A STUDY ON ULTRASOUND BASED TRANSDERMAL DRUG 
DELIVERY SYSTEM” is based on the Transdermal Drug Delivery (TDD) using 
sonophoresis. TDD offers an alternative to the oral drug delivery and provides an attractive 
alternative to the hypodermal injection too. TDD is basically a painless drug delivery 
method which offers several advantages over the conventional drug delivery methods. 
Although TDD is limited by the low permeability of the upper guarding layer of the skin, i.e. 
Stratum Corneum (SC; the upper 5
th
 layer of the epidermis) which is filled with  flat, dead 
cells and some filaments of keratin. Stratum Corneum provides a barrier to safe the 
underlying layers of the epidermis from the temperature, infection, chemicals and 
mechanical stress. 
 Several methods exist to overcome this barrier and for developing transdermal drug 
delivery such as chemical enhancers and physical mechanisms such as electroporation (use 
of a high voltage current), iontophoresis (use of low value current), and ultrasound (also 
called phonophoresis or sonophoresis, use of ultrasound) [1-4]. This remote controlled drug 
delivery system was based on the theory of low frequency ultrasound. Ultrasound has also 
been proposed as a physical enhancer, a method referred to as sonophoresis. Since the mid-
1990s that low frequency ultrasound (20 to 150 kHz) has been considered as an effective 
means of improving transdermal drug delivery. Application of low frequency ultrasound for 
medical purposes is known as sonophoresis [6-7]. Sonophoresis is widely used in hospitals 
to deliver drugs through the skin. 
 
1.1.1 How is ultrasound generated? 
Ultrasonic signals are basically sound waves which are generated beyond the human audible 
range. Only few birds like bats and few animals like dogs can hear that sounds. The sounds 
having the frequency of more than 16 kHz can be considered as ultrasound but only 20 to 50 
kHz ultrasound is used for the medical purposes. Ultrasounds are generated by device called 
a piezoelectric transducer; this piezoelectric transducer has a crystal driver which converts 
electrical energy in sounds waves. The shape of a crystal can be changed by electrical 
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simulation and by changing the shape of a crystal one can produce electrical signal. This 
effect is known as piezoelectric effect. 
 
 
Figure 1.1: Ultrasonic Generator 
 
1.2 Objective 
The objective of the thesis was to design a Sonophoresis device in which a low frequency 
ultrasound (nearby 20 KHz) had been used for the transdermal drug delivery. A temperature 
Sensor (LM35) was used for the measurement of human body temperature and the 
temperature had been displayed in a Liquid Crystal Display (LCD). 
1.2.1 Data transfer between Transmitter and Receiver using RF signal. 
When anyone switches of remote control (switch 1, 2, 3, or 4) had been pressed, the data 
were decoded by a decoder (HT12D), and then those decoded data had been transmitted 
using a RF Transmitter. The transmitted data had been received by a RF Receiver and then it 
had been encoded by an encoder (HT12E). The encoded data was send to the 
microcontroller (AT89C51) for the generation of signal which had driven the piezoelectric 
transducer to generate a low frequency ultrasound for different duty cycles. 
 
1.3 Proposed Work 
In this work, a commercially available RF Transmitter and RF Receiver along with an 
AT89C51 microcontroller had been used. A temperature sensor (LM35), for the 
measurement of human body temperature and Liquid Crystal Display (LCD), for the 
temperature display had been used. 
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1.3.1 Thesis overview 
This thesis has basically two major part, 1
st
 is Ultrasonic drug delivery & 2
nd
 is remotely 
controlled drug delivery. The overview of this thesis is as follows: 
 
Chapter 2- Review of Literature: It explains about the anatomy of stratum corneum, 
background of ultrasound, mechanism of ultrasound and ultrasonic transducer.   
 
Chapter 3- Materials and Method: It explains about different types of hydrogel preparation, 
different combinations, effect of sonication in vitro and different electronics and electrical 
components used in this project.   
 
Chapter 4- Results and Discussions: Describes the results and output of the remote 
controlled drug delivery device. 
. 
Chapter 5- Conclusion and Future work: This concludes about the remote controlled drug 
delivery system and tells about the future work. 
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Chapter 2 
 
                     Review of Literature 
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Review of Literature 
2.1 Anatomy and Physiology of Stratum Corneum 
Structurally, the skin is made up of two layers of tissue that have different histological and 
function characteristics. The first upper thin layer is called epidermis while the lower thick 
layer is called dermis. Beneath the dermis lies a third layer, consisting largely of adipose 
tissue. Although this is not part of the skin itself, this layer serves to bind the skin to 
underlying tissues and supplies it with nerves and blood vessels. This layer is called the 
hypodermis.  
Structurally, the epidermis is well adapted to its key function of preventing fluid loss 
and providing an effective physical barrier against environmental hazards. 
As figure 2.1 shows, the epidermis consists of five distinct layers of cells. Starting 
from the surface and working toward the deepest layer, these are: 
1.    Stratum corneum 
2.    Stratum lucidum 
3.    Stratum granulosum 
4.    Stratum spinosum 
5.    Stratum basale (basal layer). 
 
 
Figure 2.1: Histologic Image of Human Epidermis 
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 The stratum corneum (SC) is the outermost of the 5 layers of the epidermis, 
consisting of dead cells (corneocytes) that deficiency nuclei and organelles. Cells in the 
stratum corneum are known as „horny cells‟. They are completely filled with keratin and the 
spaces between them are filled with lipids, which binds the cells together to form a 
continuous membrane. The objective of the stratum corneum is to form a barrier to safe 
underlying tissue from dehydration, chemicals, infection and mechanical stress. To 
understand the structure and function of the stratum corneum is vital because it is the key to 
healthy skin and its associated attractive appearance. 
 
 
2.2 Background on ultrasound delivery and biological effects 
There are so many works and paper for the interaction between biological tissue and 
ultrasonic wave [11]. The ultrasound used for the diagnostic imaging is different from the 
therapeutic ultrasound. Therapeutic ultrasound gives the results as a controlled sound so that 
it can interact with the biological tissue and giving the benefit to the health. There are some  
meaningful application of this technology was developed by Francis and William Fry in the 
1950s [13]. They applied their work to make more advance their ultrasonic devices for the 
surgical treatment of neurological disorders. 
 So one can divide therapeutic ultrasound in two different types which use “low 
intensity” and “high intensity” though this division is not purely accurate. Ultrasound having 
low intensity is an appealing means of noninvasive concentration of deep tissues using 
external sources where as low intensity ultrasound can be used to deliver the drug inside the 
body and it can be clinically used in physical therapy to stimulate a normal biological 
response. Many recent reviews have shown that sonophoresis transdermal drug delivery 
offers assuring potential for noninvasive drug application [15-17].  
 
 
2.3 Mechanism of ultrasound 
Although ultrasound is known to upgrade transdermal drug delivery, the mechanisms of 
which have not been fully distinguish. Bioeffects from ultrasound includes the thermal or 
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mechanical (cavitation) mechanism. The effective principle of sonophoresis (or 
phonophoresis), is not entirely understood. It is a hypothesis that ultrasound generates an 
acoustic waves. This acoustic waves cause the result of creating micro bubbles (micro 
cavitation) in the drug molecules and tissue. Since the ultrasound is transmitted in the fluid 
media, the high amount of negative pressure causes destructive collapse in bubbles. This 
bubble creates the pathway in the skin. The other bilipid layers of the skin are temporarily 
disrupted by this acoustic wave and is cause to create a rearrangement in the SC and thus to 
pass the drug molecules inside the skin. During transient cavitation, the fast, destructive 
collapse of bubbles is associated with high acoustic pressures and temperatures of the order 
of 1000–2000 K [18]. Transient cavities are created in response to high acoustic pressures 
and/or lower frequencies.  
 The range of enhancement is calculated by four principal acoustic variables - 
intensity, frequency, duty cycle, and duration. In common, enhancement of drugs increases 
with decreasing ultrasound frequency and this is due to the fact that ultrasound causes to 
happen proportionally more cavitational activity at lower frequencies. Extending the 
duration of application or using a larger duty cycle in the case of pulsed ultrasound will 
similarly tend to increase enhancement. 
 
2.4 Ultrasonic Transducer 
Ultrasonic transducers play a very important character in nondestructive testing systems, 
ultrasonic welding instruments, ultrasonic machining technology, and ultrasonic imaging 
and diagnostic systems. Recently, ultrasound appreciated transdermal drug delivery (TDD) 
technology (sonophoresis) has taken increasing attention.  
To design and fabricate a sonophoresis device, different types of transducer can be 
used. These are mainly horn-type and the disk-type [22-24]. When the piezoelectric 
transducer operates on its fundamental resonant frequency its produces the maximum 
acoustic waves, that‟s why in most of the drug delivery system the transducer is performed 
on it fundamental frequency. This is the major drawback for the sonophoretic drug delivery 
system that it is associated by large physical size. 
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2.5 Related Work and Motivation 
 
2.5.1 Related Work 
The related works has been mentioned [25]. This paper introduces about design and 
fabrication of a sonophoresis device with different types of transducer for transdermal drug 
delivery. In this proposed sonophoresis device, a ring-shaped piezoelectric material and a 
piece of vibration metal plate were bonded together. The flat flextensional transducer was 
usually supported at the periphery and vibrates at its first flexure vibration mode. The paper 
[26] proposes a application protocol for sonophoretic transdermal delivery of a model 
hydrophilic drug. In this caffeine was selected as a model hydrophilic drug while porcine 
skin was used as a model barrier. Following acoustic validation, 20 kHz ultrasound was 
applied for different durations (range: 5 s to 10 min) using three different modes (10%, 33% 
or 100% duty cycles) and two distinct sonication procedures (either before or concurrent 
with drug deposition). The paper [27] explains about Effect of sonication parameters on 
transdermal delivery of insulin to hairless rats.  
 
2.5.2 Motivation 
Referring to the Literature survey in Paper [25, 26, 27], our work is extended to design 
microcontroller based a Remote Controlled Sonophoresis System for Transdermal Drug 
Delivery. 
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Materials & Methods 
The project entitiled with “A STUDY ON ULTRASOUND BASED TRANSDERMAL 
DRUG DELIVERY SYSTEM” has two major part, 1st  is Drug Dlivery part and 2nd is 
Electronics part that is Remote Control. Here 1
st
  Drug Dlivery part is in concern. 
3.1 Materials Required for Hydrogels Preparation 
3.1.1 Gelatin Based Hydrogels as A Matrix for Controlled Delivery 
 
3.1.1.1 Materials 
Gelatin was procured from Himedia, Mumbai, India.  Ethanol was obtained from Honyon 
International Inc., Hong Yang Chemical Corpn., China. Glutaraldehyde (25%, for synthesis; 
GA) and hydrochloric acid (35% pure) was obtained from Merck Specialties Private Limited 
Mumbai, India. Double distilled water was used throughout the study. Pilot Sl Hi-Tech Ink 
was purchased from a local student shop. 
3.1.1.2 Required Instruments 
 Sonicator- apl digital ultrasonic cleaner 
 Cooling centrifuge-REMD (C-24BL) 
 Magnetic stirrer 
 Double beam UV Spectrometer 
3.1.1.3 Standard solution for Gaur gum (1% w/v) 
0.6 gm. gaur gum was mixed with 60 ml of distilled water at magnetic stirrer, as it takes 6-7 
hours to dissolve in water completely. 
3.1.1.4 Standard solution for Glutaraldehyde (0.25% v/v) 
120 µl of 25% Glutaraldehyde was mixed with 120 ml of distilled water.  
3.1.1.5 Standard solution for Ink (0.1% v/v) 
500 µl of ink from Hi-tech point ink was mixed with 5 ml of distilled water; hence it is 10 
times diluted. Again 50 µl of this diluted ink was mixed with 5 ml of distilled water, that‟s 
why the concentration of ink was then 0.1 %v/v. 
12 
 
3.1.2. Preparation of Hydrogel 
Twenty grams of gelatin was dissolved in 200 ml of water, whose temperature was 
maintained at 50
o
C and kept on stirring at 400 rpm, so as to obtain a clear homogeneous sol.  
This resulted in the formation of a 10 % (w/v) gelatin sol (GS). Hydrogel were prepared by 
hot homogenizing (at 50
o
C) GS and Gaur gum in various proportions (GS:GG ratio being 
1:1, 3:1 and pure gelatin)  at 800 rpm for 15 min. To this homogenized hydrogel, 1.1 ml of 
GA reagent (0.5 ml GA+ 0.5 ml ethanol + 0.1 ml HCl) was added and was further stirred for 
30 sec. The mixture was then immediately poured into 100 ml beaker and was allowed to 
form gels.  The hydrogelss, so obtained, were washed thoroughly to wash off any unreacted 
GA and hydrochloric acid. 
13 
 
3.2 Materials Required for Hardware Circuit 
 
3.2.1 AT89C51 Microcontroller 
The AT89C51 is an 8-bit microcomputer from ATMEL. It has 128 bytes RAM, 4 k bytes 
flash programmable and erasable read only memory (PEROM), 2 timers and 6 interrupts. 
The high-density nonvolatile memory technology of AT89C51 makes it perfect for the 
family of MCS-51 instruction set and pin out. 
 
 
Figure 3.2.1: AT89C51 Microcontroller 
 
3.2.1.2 Features of AT89C51 Microcontroller 
 
 Compatible with MCS-51™ Products 
 4 K Bytes of In-System Reprogrammable Flash Memory 
 Fully Static Operation: 0 Hz to 24 MHz 
 Three-level Program Memory Lock 
 128 x 8-bit Internal RAM 
 32 Programmable I/O Lines 
 Two 16-bit Timer/Counters 
 Six Interrupt Sources 
 Programmable Serial Channel 
 Low-power Idle and Power-down Modes. 
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3.2.1.3 Architecture and Pin Configuration of AT89C51 
The following figure 3.2.2 is the architecture given by the manufacturer: 
 
Figure 3.2.2: Architecture of AT89C51 
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The following figure 3.2.3 illustrates the Pin Configuration of AT89C51: 
 
 
 
 
Figure 3.2.3: Pin configuration 
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3.2.2 7805 Voltage Regulator 
A voltage regulator is for to supply a constant voltage level. The 78xx family comprises of 
commonly used voltage regulators which provide a positive regulated power supply and 
they are less expensive. The voltage regular 7805 is a regulated power supply which will 
generate constant 5 V. It is 3 pin self-contained fixed linear voltage regulator integrated 
circuit. Similarly 79xx family comprises of commonly used voltage regulators which 
provide a negative regulated power supply. The xx is replaced with two digits, indicating the 
output voltage. 
 
 
Figure 3.2.4: 7805 Voltage Regulator 
 
3.2.3 Temperature Sensor LM35 
The LM35 series are accurate IC temperature sensors. The output of LM35 is linearly 
proportional to the Celsius (Centigrade) temperature. For 1ºC  it will give 10 mV output. 
The LM 35 does not require any external calibration or correction to provide typical 
accuracies of ±1⁄4˚C at room temperature and ±3⁄4˚C over a full −55 to +150˚C temperature 
range. 
 
Figure 3.2.5: LM 35 Temperature Sensor 
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3.2.4 Encoder/Decoder 
The encoder/decoder is used before and after transmitter and receiver. The encoder is used 
for encoding parallel data to serial data for serial transmission. The received data from the 
RF receiver is decoded to parallel data using decoder. In this project work HT12E encoder 
and HT12D decoder had been used. These are basically 18 pin Integrated Circuits. 
 
Figure 3.2.6: Encoder HT12E & Decoder HT12D 
 
3.2.4.1 Pin Assignment Of Encoder And Decoder 
 
Figure 3.2.7: Pin Assignment Of Encoder And Decoder 
 
3.2.5 LM358 
LM358 is an 8-pin Integrated Circuit. It contains two low power operational amplifiers. The 
LM358 is generally used as amplifiers, all types of filters and analog adders. The main 
advantage of using this LM358 in place of OP741 is that it can operate with a single static 
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power supply. This power supply can be varying between a minimum of 3 V to a maximum 
of 32 V. While using single power supply the LM358 can be connected to the positive 
power only while the negative supply is replaced by the mass. 
 
 
Figure 3.2.8: LM358 
 
3.2.6 RF Module 
Radio Frequency (RF) Modules are most widely used wireless transfer data. This makes 
them most suitable for remote control applications. The RF module which is used in this 
project is operated on 433 MHz. 
 
3.2.6.1 Features of RF Module 
 Range in open space (Standard Condition) : 100 Meters 
 TX supply voltage : 3V – 6V 
 Low Power Consumption 
 RX Receiver Frequency : 433 MHz 
 RX Typical Sensitivity: 105 dBm. 
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3.2.6 ADC0804 
The ADC080X fanily of the ADC0800 series from National Semiconductor. The ADC0804 
is an 8 bit parallel Integrated Circuit. This IC requires +5 V power supply for operation and 
it has resolution of 8 bit, hence the number of steps will be 256. Thus for +5 V power supply 
(if pin. 9 is not connected) the step size will be 19.53 mV. ADC0804 has two clocks, one is 
external and another one is internal clock. The conversion time i.e. to the time for analog to 
digital conversion, depends upon the clocking signals. The conversion time cannot be faster 
than 110µs. if the resolution is high, it will provide a smaller step size, where step size is the 
smallest change that can be detected by an ADC. Conversion time is defined as the time it 
takes the ADC to convert the analog input to a digital number and is dependent the value of 
the resistance and capacitor fixed with the pin number 4.  
 
 
Figure 3.2.10: ADC 0804 
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Results and Discussions 
 
4.1 Standard Absorbance Curve for Ink 
500 µl of ink from Hi-tech point ink was mixed with 5 ml of distilled water; hence it was 10 
times diluted. Again 50 µl of that diluted ink was mixed with 5 ml of distilled water, that‟s 
why the concentration of ink was then 0.1 %v/v. 
 In test tube 1
st
, took 1 ml of 0.1 %v/v and 4 ml of water, so the concentration of the 
ink in the test tube 1
st
 was then 0.04 %v/v. Similarly in test tube 2
nd
 2 ml of ink and 3 ml of 
water, in test tube 3
rd
 3 ml of ink and 2 ml of water, in test tube 4
th
 4 ml of ink and 1 ml of 
water and in test tube 5
th
 5 ml of ink (fig. 4.1). The concentration of the ink in the respective 
test tubes and their optical density taken at 585.5 nm is given in the table below: 
Table 4.1: Standard Absorbance Curve for Ink 
S. No. Conc. Of Ink (µl/ml) Absorbance(585.5nm) 
1 0.02 0.0903 
2 0.04 0.1743 
3 0.06 0.2903 
4 0.08 0.3414 
5 0.10 0.4204 
  
 
 
 
 
 
 
 
 
 
 
Figure 4.1: Sample of inks for the standard graph 
1 2 3 4 5 
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On the basis of the above table, plot the curve in Origin Pro 8 software. 
 
Figure 4.2: Standard Absorbance Curve for Ink 
 
Result: The curve is a straight line as expected. 
 
4.2 Preparation of Hydrogels 
The various compositions of the hydrogel have been tabulated in table 4.2.  
Table 4.2: Composition of Hydrogels 
S. No. Gelatin Gaur gum V/V Ratio W/V Ratio 
1. 20 ml - - - 
2. 10 ml 10 ml 1:1 10:1 
3. 15 ml 05 ml 3:1 30:1 
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Figure 4.3: Standard Solution 
 
In this 20 ml solution of gelatin and gaur gum, mixed 300 µl of standard ink 3.33% 
and 1.1 ml of GA reagent (0.5 ml GA+ 0.5 ml ethanol + 0.1 ml HCl) was added and was 
further stirred for 30 sec and after that keep this solution for 3-4 hours for the gel formation. 
 
4.3 Sonication of Hydrogels 
After the gel formation, put 10 ml distilled water in all the beakers and take out the water 
after sonication for the ink absorption using optical density measurement. 
So we had made the 4 different samples for different duty cycles of sonication (fig. 
4.4). Standard solution will be used as without sonication, solution 1 will be used for 10% 
duty cycle of sonication, 2
nd
 will be used for 33% duty cycle of sonication and 3
rd
 will be 
used for 100% duty cycle of sonication (fig. 4.5). 
 
 
                                     Figure 4.4: Set of Solutions 
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Figure 4.5: Sonication Time (duty Cycles) 
 
4.4 Spectrometer Reading of Different Samples (hydrogels) 
After sonication of all the samples, take the spectrometer reading for the absorption of the 
ink in the distilled water. The spectrometer reading is shown below in table 4.3. 
Table 4.3: Spectrometer Reading of Different Samples (hydrogels) 
S. No. Sample Pure Gelatin Gelatin: GG(1:1) Gelatin: GG(15:5) 
1 Standard Sol. 0.0130 0.0150 0.0115 
2 1 0.0107 0.0306 0.0608 
3 2 0.0156 0.0322 0.0357 
4 3 0.0248 0.0320 0.0451 
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4.4.1 Calculation Table 
On the basis of the spectrometer reading the calculation has been done and the calculation 
table is shown below in the table: 
Table 4.4: Calculation Table 
S. No. Optical Density µg/ml µg/10 ml % of Release of ink 
1. 0.0130 0.00598 0.0598 0.598 
2. 0.0150 0.0069 0.069 0.69 
3. 0.0115 0.0053 0.053 0.53 
4. 0.0107 0.00493 0.0493 0.493 
5. 0.0306 0.00141 0.0141 0.141 
6. 0.0608 0.0280 0.280 2.80 
7. 0.0156 0.0072 0.072 0.72 
8. 0.0322 0.01483 0.1483 1.483 
9. 0.0357 0.01644 0.1644 1.644 
10. 0.0248 0.01142 0.1142 1.142 
11. 0.0320 0.014736 0.14736 1.4736 
12. 0.0451 0.021 0.21 2.1 
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4.5 Graphs for the concentration of ink released 
On the basis of the calculation table, the % absorption of ink in the distilled water has been 
plotted using Origin Pro 8 software. The graph for the concentration of ink released is 
shown below in the figure 4.7. 
 
 
Figure 4.7: Graphs for the concentration of ink released 
27 
 
4.6 Resonant Frequency of Piezoelectric Transducer 
The piezoelectric transducer can be considering as a series RLC circuit. The resonance of a 
series RLC circuit occurs when the inductive and capacitive reactance are equal in 
magnitude but cancel in each other because they are 180
0 
apart in phase. The RLC circuit 
has a minimum of impedances Z=R at the resonant frequency and the phase angle is equal to 
zero at resonance. 
 
4.6.1 Block diagram 
The block diagram of resonant frequency circuit is shown below. In this circuit a function 
generator is used for the supply of alternative voltage with variable frequency from 200 Hz 
to 25 MHz. A CRO is used for the measurement of output voltage from the load resistance 
of 100 ohms.  
 
Figure 4.8: Block diagram of frequency measurement circuit 
 
4.6.2 Circuit Diagram 
The circuit diagram is shown below; 
 
Figure 4.9: Circuit Diagram of Resonant Frequency Measurement 
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4.6.3 Output voltage across the load resistance 
The table between frequency variation and output voltage in CRO is given below. As well as 
the frequency of the input signal is increasing the output voltage across load resistance is 
also increasing. The whole circuit is behaving like a low pass filter. 
 The supply voltage is 10 VPk-Pk and the value of the load resistance is 100 Ohms. 
Table 4.5: Measurement Table 
S. No. Frequency (Hz) VPK-PK  Range(Volt) VPK-PK (Volt) 
1. 500 7.76 - 7.84 7.80 
2. 700 8.32 - 8.40 8.36 
3. 900 8.70 - 8.80 8.75 
4. 1000 8.96 - 9.04 9.00 
5. 1100 9.20 – 9.28 9.24 
6. 1200 9.36 – 9.44 9.40 
7. 1300 9.44 – 9.52 9.48 
8. 1400 9.60 – 9.68 9.64 
9. 1500 9.68 – 9.76 9.72 
10. 1600 9.76 – 9.84 9.80 
11. 1700 9.84 – 9.92 9.84 
12. 1800 9.92 – 10.10 10.01 
13. 1900 9.92 – 10.10 10.01 
14. 2000 10.00 – 10.10 10.05 
15. 2100 10.00 – 10.10 10.05 
 16. 2200 10.00 – 10.10 10.05 
17. 2300 10.00 – 10.10 10.05 
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4.6.4 Graph for the Calculation of Resonant Frequency of Piezoelectric Transducer 
On the basis of the measurement table the graph has been plotted using Origin Pro 8 
software. The graph for the Calculation of Resonant Frequency of Piezoelectric Transducer 
is shown below in the figure 4.7. 
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Figure 4.10: Graph for resonant frequency of Piezoelectric Transducer 
 
4.6.5 Result 
From the graph it is very clear that the piezoelectric transducer is behaving like a low pass 
filter and the cut off frequency (Resonant Frequency for the RLC circuit) is 1.999 KHz. 
 
 
Figure 4.11: CRO Output for Resonant Frequency Measurement 
30 
 
4.7 Generation of 20 KHz Frequency of sine wave using ICL8038 IC 
The sine wave signal generator was developed using a monolithic ICL8038. The designed 
circuit has been shown in figure 4.12. The circuit was designed to generate sinusoidal signal 
of variable frequency in the range of 100 Hz to 25 KHz. The frequency of the generated 
signal may be controlled by varying the R1 and C1 components. A potentiometer of 10 KΩ 
was used as R1 while 0.1 µF and 0.001 µF capacitors were used for generating frequency in 
the range of 100 Hz-1 KHz and 1 KHz-25 KHz, respectively. The amplitude of the 
sinusoidal signal may be altered by varying R2, R3 and R4 resistors. When R2, R3 and R4 
was chosen as 15 KΩ, 1 KΩ and 15 KΩ, respectively, the amplitude of the sinusoidal 
waveform was found to be 4.6 Vpp. The stability of the signal generator was determined by 
determining the Vpp and Vrms across the frequency range. The results have been shown in 
table 4.6. The results suggested that the output of the signal generator was stable in the 
desired frequency range of 100 Hz to 25 KHz. The output of the signal generator was fed 
into a unity gain voltage buffer working in the non-inverting mode (figure 4.2). This was 
done to ensure that the signal generator is not affected due to the loading effect. The signal 
generator followed by the voltage buffer was regarded as the sinusoidal waveform generator 
(SWG).  
               
Figure 4.12: Circuit diagram of sine wave signal generator 
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Table 4.6: The output stability of IC 8038 
 
S. No. Frequency (Hz) VPK-PK (Volt) VRMS (Volt) 
1. 100 4.60 1.626 
2. 300 4.60 1.626 
3. 500 4.60 1.626 
4. 700 4.60 1.626 
5. 900 4.53 1.601 
6. 1000 4.53 1.601 
7. 2000 4.53 1.601 
8. 3000 4.53 1.601 
9. 4000 4.53 1.601 
10. 5000 4.53 1.601 
 
 
Figure 4.13: Schematic representation of sinusoidal waveform generator. 
 
 
Figure 4.14: Generation of 21 KHz Frequency of sine wave using ICL8038 IC 
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4.8 Design and Fabrication of a Remote Controlled Drug Delivery System 
The development of an ultrasound based transdermal drug delivery device had received 
increasing attention over the recent years. In this project we had designed a low cast 
optimized sonophoresis device with variable resonant frequency for studying transdermal 
drug delivery in vitro.  
4.8.1 Simulation of Circuit Diagram in Proteus ISIS 
The simulation of circuit diagram in Proteus ISIS for LED blinking program using 
microcontroller AT89C51 with temperature sensor LM35 is shown below (figure 4.15). 
Figure 4.15: Simulation of Led Blinking Program Using Microcontroller “AT89C51” 
With Temperature Sensor “LM35” 
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4.8.2 Use of LED Blinking Output 
This was the main output, which was used for the supplying of the power supply voltage for 
the sine wave signal generator ICL8038 to generate a sine wave of 21 KHz frequency. This 
sine wave was used as an alternative voltage source for the operating of piezoelectric 
transducer to generate ultrasound for transdermal drug delivery. In the simulation software 
the LED was blinking for different duty cycle. The programming was done in this manner, 
like if switch 1
st
 from the remote control section was pressed; the LED was glowing 
continuously until the switch 1
st
 is unpressed. When the switch 2
nd
 was pressed once; the 
LED was glowing exactly for 3 sec and after that it was off for exactly 27 sec. Again it was 
on for 3 sec and off for 27 sec. The whole process was repeated for three times. Similarly 
when the 3
rd
 switch was pressed once; the LED was glowing exactly for 10 sec and after that 
it was off for exactly 20 sec. Again it was on for 10 sec and off for 20 sec. The whole 
process was repeated for three times. Similarly when the 4
th
 switch was pressed once, the 
LED was on for 30 sec continuously and after that it was off automatically. 
4.8.3 Remote Control Section of Drug Delivery Device 
The remote control of the drug delivery device is shown below.  
 
Figure 4.16: Remote Control Section of Remote Controlled Drug delivery Device  
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4.8.4 Temperature Output of Remote Controlled Drug Delivery Device  
The receiver part of the drug delivery device is shown below in which temperature sensor 
LM35 was inbuilt to measure the body temperature. The circuit uses IC LM35 as the 
temperature sensor. The output of LM 35 is given to the IC ADC0804 which converts the 
analog output of the LM35 to digital output. Again this digital output is given to the 
microcontroller AT89C51 to process and display the temperature in LCD display. 
 
Figure 4.17: Temperature Output of Remote Controlled Drug Delivery Device 
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4.9 Generating 21 KHz frequency from the circuit remotely 
Here with the help of designed circuit, a sine wave of 21 KHz frequency was generated to 
operate the piezoelectric transducer to produce low frequency ultrasound (20 KHz) for the 
transdermal drug delivery. In this circuit microcontroller was used for the generating of a 
pulse having different duty cycles (10%, 33% & 100%). The output of the microcontroller 
was used as the power supply for the signal generator IC 8038, which was the main IC for 
the generation of sine wave having 21 KHz frequency. The output frequency is shown in a 
CRO. The output of the designed circuit is shown below in the figure 4.18.  
 
Figure 4.18: 21 KHz Frequency Generating From the Circuit 
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4.10 Remote Controlled Drug Delivery System 
4.10.1 When none switch is pressed 
When the circuit (or device) was in relaxing condition, it means that there was no command 
from the remote, that‟s why the device was only showing environmental temperature. 
 In the receiver section there were two indicating element that showed that any one of 
switch from remote section had been pressed.  1
st
 indicating element was LED and 2
nd
 was a 
buzzer. In the figure shown below neither led was glowing nor buzzer was ringing; which 
showed that none switch is pressed from remote section (fig. 4.19). 
 
 
Figure 4.19: Remote controlled drug delivery device when none switch is pressed 
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4.10.2 When switch 1
st
 is pressed 
When switch 1
st
 was pressed, the indicating LED was glowing and at the same time the 
buzzer was ringing and the piezoelectric transducer was generating the low frequency 
ultrasound. This low frequency ultrasound was used for the delivery of drug. The LCD was 
displaying the temperature simultaneously, but when the switch 2
nd
 was pressed, the 
indicating LED was glowing and the piezoelectric transducer was generating the low 
frequency ultrasound for exactly 3 second and they were off for exactly 27 seconds. The 
whole process was repeated for 3 times. During the process of generating low frequency 
ultrasound the temperature was constant and after finishing the process the LCD was 
displaying the modified temperature. Thus the temperature difference had been calculated. 
 
Figure 4.20: Remote Controlled Drug Delivery Device When Switch 1
st
 Is Pressed 
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Conclusion and Future Work  
5.1 Conclusion 
The current study dealt with the design of a remote controlled drug delivery system which 
can work efficiently in the frequency range of 20 KHz to 40 KHz. The circuit was found to 
be stable in the operating frequency range. The developed system was tested to generate the 
low frequency ultrasound. Here in this system one can change the frequency of the 
ultrasound as well as the time for the sonication. This study showed that the most practical 
regimen for sonophoretic drug delivery was a concurrent 5 min, pulsed (10% duty cycle) 
beam. It can be easily calculated the increment of the temperature due to the sonication. 
5.2 Future Work 
The use of transdermal drug delivery methods has the most practical clinical application for 
medications that need to be injected multiple times either daily or weekly. The future works 
are as follows: 
 Since in this project, intensity of the ultrasound had not been considered, that is also 
a very important component for the appropriate delivery of drug in transdermal drug 
delivery. 
 Since in this project, the reset button of the microcontroller is not remotely 
controlled. It will be better to control remotely the reset button also. 
 Since in this project, the frequency of the ultrasound is varying manually. It also can 
be controlled remotely. 
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